Researchers find genes, corresponding proteins that may lead to new depression treatments

Using an innovative protein-based approach, researchers at the Atlanta Veterans Affairs Medical Center and nearby Emory University have found genes and corresponding proteins that could point the way to new depression treatments. Using a proteome-wide association study (PWAS) that integrated genome-wide association study (GWAS) data with human brain proteomic and genetic data, researchers have identified […]

Continue Reading

Study provides new insights into resistance to immune checkpoint inhibitors

New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy. The study was presented today at the American Association of Cancer Research (AACR) virtual annual meeting. “Acquired resistance to immune checkpoint inhibitors is a growing clinical challenge. About 50% of lung cancer patients who initially […]

Continue Reading

Researchers developing probiotic yogurt-based drugs

Researchers at Ben-Gurion University of the Negev (BGU) have for the first time identified new drug candidates based on molecules isolated from probiotic Kefir yogurt for combating pathogenic bacteria and treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, published in Microbiome, a leading peer-reviewed publication was led […]

Continue Reading

Better treatment for aggressive prostate cancer

New research from CU Cancer Center member Scott Cramer, Ph.D., and his colleagues could help in the treatment of men with certain aggressive types of prostate cancer. Published this week in the journal Molecular Cancer Research, Cramer’s study specifically looks at how the loss of two specific prostate tumor-suppressing genes—MAP3K7 and CHD1 —increases androgen receptor […]

Continue Reading